Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|July 2, 2021
Predictors of Oral Infection by Mucosal and Cutaneous Human Papillomaviruses in HIV-Infected and Uninfected Men Who Have Sex with Men of the OHMAR StudyMassimo Giuliani, Tarik Gheit, Francesca Rollo, et al.
Sexually Transmitted Infections|November 18, 2021
Molecular characterisation and antibiotic susceptibility of meningococcal isolates from healthy men who have sex with menArianna Neri, Annapina Palmieri, Grazia Prignano, et al.
BMC Cancer|October 18, 2012
Anal cytological abnormalities and epidemiological correlates among men who have sex with men at risk for HIV-1 infectionMaria Gabriella Donà, Maria Benevolo, Amina Vocaturo, et al.
Journal of the International AIDS Society|November 15, 2014
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohortCarmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.
BMC Infectious Diseases|August 13, 2016
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational studyAlessandra Latini, Massimiliano Fabbiani, Vanni Borghi, et al.
Biomed Research International|December 27, 2013
Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based studyMassimo Giuliani, Maria M Santoro, Alessandra Lo Presti, et al.
Journal of the International AIDS Society|November 15, 2014
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysisMauro Zaccarelli, Massimiliano Fabbiani, Carmela Pinnetti, et al.
AIDS Research and Human Retroviruses|October 1, 2020
Overall Tolerability of Integrase Inhibitors in Clinical Practice: Results from a Multicenter Italian CohortArturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
Le Infezioni in Medicina|December 18, 2019
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort studyGianmaria Baldin, Arturo Ciccullo, Stefano Rusconi, et al.
Viruses|January 22, 2022
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian CohortArturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
Pageof 11